SHH and chronic kidney disease: According to the results obtained after the inhibition of the Shh signaling pathway in vivo and the upregulation and downregulation of the Shh pathway in vitro, we postulate that the Shh signaling pathway is involved in the process of myocardial fibrosis caused by CKD, and interventions targeting Shh signaling are a feasible treatment option.